Hofseth Biocare ASA Cash Flow Reinvestment Rate
Hofseth Biocare ASA cash flow reinvestment rate. Hofseth Biocare ASA (HBC) has a Cash Flow Reinvestment Rate of 2.87x as of December 2024, reinvesting Nkr2.44 Million (capex Nkr1.22 Million plus investments Nkr-1.22 Million) from operating cash flow of Nkr851.00K. See HBC FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hofseth Biocare ASA (2015–2023)
Cash flow reinvestment rate of Hofseth Biocare ASA from 2015 to 2023. Historical reinvestment intensity for Hofseth Biocare ASA across 2 annual periods. Explore HBC debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Hofseth Biocare ASA Cash Flow Reinvestment Rate by Year (2015–2023)
Hofseth Biocare ASA cash flow reinvestment rate by year from 2015 to 2023. Year-by-year capital reinvestment analysis for Hofseth Biocare ASA. For the full cash flow conversion analysis, see HBC operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 9.51x | Nkr26.25 Million | Nkr2.76 Million | Nkr8.19 Million | ▲ +512.0% |
| 2015 | 1.55x | Nkr12.37 Million | Nkr7.97 Million | Nkr11.84 Million | — |